US 11667718
Cancer treatment
granted A61KA61K2039/505A61K31/165
Quick answer
US patent 11667718 (Cancer treatment) held by VANDA PHARMACEUTICALS INC. expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VANDA PHARMACEUTICALS INC.
- Grant date
- Tue Jun 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505, A61K31/165, A61K38/00, A61K9/0019